| Balance Sheets | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,237,010 | 1,238,459 | 1,990,683 | 1,958,633 |
| Marketable securities (includes 2,788,781 of available-for-sale marketable securities held at fair value as of september 30, 2025) | 3,148,825 | 3,264,692 | 3,155,825 | 3,428,021 |
| Other current assets | 125,811 | 112,600 | 217,460 | 94,226 |
| Current assets of discontinued operations (note 6) | - | - | 0 | 320,239 |
| Total current assets | 4,511,646 | 4,615,751 | 5,363,968 | 5,801,119 |
| Property and equipment, net | 25,667 | 14,865 | 13,563 | 13,674 |
| Operating lease right-of-use assets | 85,136 | 87,078 | 90,895 | 42,977 |
| Investments measured at fair value | 412,315 | 283,814 | 290,040 | 311,354 |
| Other assets | 27,834 | 31,094 | 33,879 | 36,904 |
| Noncurrent assets of discontinued operations (note 6) | - | - | 0 | 0 |
| Total assets | 5,062,598 | 5,032,602 | 5,792,345 | 6,206,028 |
| Accounts payable | 15,064 | 11,550 | 23,712 | 25,127 |
| Accrued expenses | 108,315 | 88,728 | 104,324 | 111,469 |
| Operating lease liabilities | 9,002 | 9,402 | 9,835 | 9,519 |
| Other current liabilities | 1,476 | 4,186 | 3,613 | 8,921 |
| Current liabilities of discontinued operations (note 6) | - | - | 0 | 401,213 |
| Total current liabilities | 133,857 | 113,866 | 141,484 | 556,249 |
| Liability instruments measured at fair value | 33,269 | 12,310 | 24,105 | 26,252 |
| Operating lease liabilities, noncurrent | 89,844 | 90,292 | 90,479 | 43,190 |
| Other liabilities | 170 | 228 | 307 | 295 |
| Noncurrent liabilities of discontinued operations | - | - | 0 | 0 |
| Total liabilities | 257,140 | 216,696 | 256,375 | 625,986 |
| Additional paid-in capital | 4,771,880 | 4,644,085 | 4,721,017 | 4,775,411 |
| (accumulated deficit) / retained earnings | -429,107 | -315,588 | 460,398 | 395,580 |
| Accumulated other comprehensive income | 19,558 | 17,137 | 8,057 | -18,036 |
| Shareholders equity attributable to roivant sciences ltd | 4,362,331 | 4,345,634 | 5,189,472 | 5,152,955 |
| Noncontrolling interests | 443,127 | 470,272 | 346,498 | 427,087 |
| Total shareholders equity | 4,805,458 | 4,815,906 | 5,535,970 | 5,580,042 |
| Total liabilities and shareholders equity | 5,062,598 | 5,032,602 | 5,792,345 | 6,206,028 |
Roivant Sciences Ltd. (ROIV)
Roivant Sciences Ltd. (ROIV)